February 27, 2020 / 11:05 PM / a month ago

BRIEF-Denali Therapeutics Inc Posts Qtrly Loss Per Share Of $0.56

Feb 27 (Reuters) - Denali Therapeutics Inc:

* DENALI THERAPEUTICS REPORTS FULL YEAR 2019 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

* QTRLY LOSS PER SHARE $0.56

* QTRLY COLLABORATION REVENUE $4.7 MILLION VERSUS $125.7 MILLION

* Q4 EARNINGS PER SHARE VIEW $-0.58 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below